Screener
Kura Oncology KURA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
| Line item | March 31, 2026 | December 31,2025 |
|---|---|---|
| Accounts receivable, net | 9,348 | 8,804 |
| Inventory | 843 | 413 |
| Prepaid expenses and other current assets | 32,768 | 32,206 |
| Total current assets | 623,782 | 708,663 |
| Property and equipment, net | 7,613 | 7,855 |
| Operating lease right-of-use assets | 7,166 | 7,302 |
| Other long-term assets | 13,990 | 14,543 |
| Total assets | $652,551 | $738,363 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Kura Oncology's total current assets?
- Kura Oncology (KURA) reported total current assets of $623.78M in Q1 2026.
- How has Kura Oncology's total current assets changed year-over-year?
- Kura Oncology's total current assets decreased by 13.9% year-over-year, from $724.2M to $623.78M.
- What is the long-term trend for Kura Oncology's total current assets?
- Over 5 years (2020 to 2025), Kura Oncology's total current assets has grown at a 2.1% compound annual growth rate (CAGR), from $637.29M to $708.66M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Kura Oncology's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude